Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04810624 · ClinicalTrials.gov registry record · NA
Relapse Prevention and Changing Habits in Anorexia Nervosa
A NA study, sponsored by New York State Psychiatric Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04810624 is a NA study that is actively recruiting participants, run by New York State Psychiatric Institute. The registered enrollment target is 60 participants.
The verdict
NCT04810624, a NA study, is actively recruiting participants, sponsored by New York State Psychiatric Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study aims to optimize a treatment package for the relapse prevention treatment of AN. In the Preparation Phase, we examined accessibility and feasibility of the treatment package. In the current Optimization Phase, we will identify which components of treatment contribute to positive outcomes after acute hospitalization. We will carefully evaluate maintenance of remission, measured by rate of weight loss and end-of-trial status.
Interventions
- BEHAVIORAL Relapse Prevention and Changing Habits (REACH+)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-06-21 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04810624
The ClinicalTrials.gov registry entry for NCT04810624 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Relapse Prevention and Changing Habits (REACH+) is the first listed.
NCT04810624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04810624 about?
NCT04810624 is a clinical study titled "Relapse Prevention and Changing Habits in Anorexia Nervosa". This study aims to optimize a treatment package for the relapse prevention treatment of AN. In the Preparation Phase, we examined accessibility and feasibility of the treatment package. In the current Optimization Phase, we will identify which components of treatment contribute to positive outcomes...
What is the current status of trial NCT04810624?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-06-21. Estimated completion is 2027-06-01.
What interventions are being tested in trial NCT04810624?
The interventions under investigation include: Relapse Prevention and Changing Habits (REACH+) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04810624?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.